SARS-CoV-2 antibodies can bind to two viral targets at once – Drug Target Review

1. SARS-CoV-2 antibodies can bind to two viral targets at once  Drug Target Review
2. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression  The Lancet
3. Controversial new research suggests SARS-CoV-2 bears signs of genetic engineering | Mint  Mint
4. Tight transmission bottlenecks may limit the evolution of SARS-CoV-2 variants  News-Medical.Net
5. The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era  The Lancet
6. View Full coverage on Google News

Source: News feed